Literature DB >> 7715296

Is Alzheimer's disease an apolipoprotein E amyloidosis?

T Wisniewski1, M Lalowski, A Golabek, T Vogel, B Frangione.   

Abstract

The presence of the apolipoprotein E4 allele has been identified as a major risk factor for late-onset Alzheimer's disease. Apolipoprotein E has also been found immunohistochemically in Alzheimer's disease lesions. We biochemically isolated amyloid beta from senile plaques and found that a carboxyl-terminal fragment (residues 216-299) of apolipoprotein E co-purified. In vitro this fragment from recombinant apolipoprotein E could form amyloid-like fibrils, which were Congo-red positive. Thus senile plaques may contain both amyloid beta and apolipoprotein E amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715296     DOI: 10.1016/s0140-6736(95)90701-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.

Authors:  V Jelic; P Julin; M Shigeta; A Nordberg; L Lannfelt; B Winblad; L O Wahlund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Presenilin-1 is associated with Alzheimer's disease amyloid.

Authors:  T Wisniewski; W K Dowjat; B Permanne; J Palha; A Kumar; G Gallo; B Frangione
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE.

Authors:  Lars N G Nilsson; Sylvia Gografe; David A Costa; Tiffany Hughes; David Dressler; Huntington Potter
Journal:  Technol Innov       Date:  2012-02-01

4.  High levels of homocysteine results in cerebral amyloid angiopathy in mice.

Authors:  Jian-Guo Li; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 5.  Amyloid-beta immunisation for Alzheimer's disease.

Authors:  Thomas Wisniewski; Uwe Konietzko
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

6.  A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; James A Ripellino; Yongsheng Li; Stephen D Schmidt; Paul M Mathews; John D Fryer; David M Holtzman; Einar M Sigurdsson; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

7.  A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain.

Authors:  Sergey V Matveev; Hans Peter Spielmann; Brittney M Metts; Jing Chen; Fredrick Onono; Haining Zhu; Stephen W Scheff; Lary C Walker; Harry LeVine
Journal:  J Neurochem       Date:  2014-07-28       Impact factor: 5.372

Review 8.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 10.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.